We have updated our Privacy Policy and Terms of Use. By accessing or using this Website, you accept and agree to be bound by our Privacy Policy and our Terms of Use.
If you do not agree with our policies, do not access or use our website. Our Privacy Policy explains the types of information we may collect from you or that you may provide,
as well as our practices for collecting, using, maintaining, protecting, and disclosing that information.
Accept

Advocacy


Published on Jan 27, 2020

Greater access to opioid medication the focus of bills

Contact: Sharon Swanson, Jacob Ewing

Legislators heard public testimony in both the House and Senate on expanded patient access to medication used to treat opioid addiction.

HB 2335, sponsored by Rep. Lauren Davis (D–Shoreline), and companion SB 6086, sponsored by Sen. Bob Hasegawa (D–Seattle), allow a health care entity to administer, dispense, or deliver up to a two-week supply of medication to a patient receiving evidence-based opioid use disorder treatment. This is an increase from the previous limit of 72 hours.

 

Dates to remember


HB 2335 is scheduled for executive session in the House Health Care & Wellness Committee at 8 am on Friday, January 31.

  • Advocacy
  • Public safety & criminal justice
  • Homelessness

 

Recent articles


Related content

bill-iconAWC's bill tracker

Visit AWC’s bill tracker to learn about legislation with city impacts this year.

Copyright © 2018-2025 Association of Washington Cities